Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WuXi Biologics (Cayman)'s Total Tax Payable for the quarter that ended in Dec. 2025 was MXN2,308 Mil.
WuXi Biologics (Cayman)'s quarterly Total Tax Payable
declined
from Dec. 2024 (MXN2,063 Mil) to Jun. 2025 (MXN1,547 Mil) but then
increased
from Jun. 2025 (MXN1,547 Mil) to Dec. 2025 (MXN2,308 Mil).
WuXi Biologics (Cayman)'s annual Total Tax Payable
increased
from Dec. 2023 (MXN1,676 Mil) to Dec. 2024 (MXN2,063 Mil) and
increased
from Dec. 2024 (MXN2,063 Mil) to Dec. 2025 (MXN2,308 Mil).
WuXi Biologics (Cayman) Total Tax Payable Related Terms
WuXi Biologics (Cayman) Total Tax Payable Historical Data
* Premium members only.
The historical data trend for WuXi Biologics (Cayman)'s Total Tax Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WuXi Biologics (Cayman) Total Tax Payable Calculation
Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.
What does a Total Tax Payable of MXN2,308 Mil mean?
WuXi Biologics (Cayman) (MEX:2269N) has a Total Tax Payable of MXN2,308 Mil as of Dec. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on WuXi Biologics (Cayman) and its competitors.
Is WuXi Biologics (Cayman)'s Total Tax Payable too high?
WuXi Biologics (Cayman)'s current Total Tax Payable is MXN2,308 Mil. Overall, WuXi Biologics (Cayman) has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does WuXi Biologics (Cayman)'s Total Tax Payable compare to VRTX and REGN?
WuXi Biologics (Cayman)'s Total Tax Payable of MXN2,308 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on WuXi Biologics (Cayman) and its competitors. WuXi Biologics (Cayman)'s current Total Tax Payable is MXN2,308 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi Biologics (Cayman) stock overvalued right now?
WuXi Biologics (Cayman) (MEX:2269N) has a current Total Tax Payable of MXN2,308 Mil. The stock's GF Value™ is MXN54.50, compared to a current price of MXN62.53 — trading 14.7% above its estimated fair value. The current Total Tax Payable is MXN2,308 Mil. WuXi Biologics (Cayman)'s overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For WuXi Biologics (Cayman) (MEX:2269N), the current Total Tax Payable is MXN2,308 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WuXi Biologics (Cayman) (MEX:2269N) Overvalued in 2026?
Based on GuruFocus' analysis, WuXi Biologics (Cayman) stock appears to be overvalued.
The current stock price of MXN62.53 is trading 14.7% above its estimated GF Value™ of MXN54.50.
Key valuation signals for MEX:2269N:
Total Tax Payable: MXN2,308 Mil
GF Value™: MXN54.50 vs. price of MXN62.53 (14.7% above fair value)
No single metric tells the full story. See the MEX:2269N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WuXi Biologics is one of the largest biologics contract development and manufacturing organizations in the world. Incorporated in 2014 following the reorganization of WuXi PharmaTech, WuXi engages in full-lifecycle services beginning from drug discovery, clinical trials, and commercial manufacturing. It focuses on developing refining and manufacturing processes to increase scalability and efficiency for pharmaceutical companies looking to outsource and access specialized knowledge. As of 2024, WuXi derives more than 60% of its revenue from US companies and focuses its operations on high-growth, late-stage, and commercial projects in the biologics sector. WuXi competes with Samsung Biologics, Lonza, and Fujifilm for contracts.
97GF Score
Get the complete analysis for MEX:2269N
Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:2269N has been successfully added to your 
